Tokyo, May 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061226) titled 'A Prospective Cohort Study on the Incidence of Postoperative Bleeding Complications in Inguinal Hernia Repair Under Antiplatelet Therapy' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - The Jikei University School of Medicine
Condition:
Condition - inguinal hernia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the incidence of postoperative hemorrhagic complications in adult patients undergoing inguinal hernia repair while continuing antiplatelet therapy.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years or older.
Patients scheduled for unilateral or bilateral inguinal hernia repair.
Patients currently receiving antiplatelet therapy (including dual or multiple antiplatelet therapy).
Key exclusion criteria - Emergency surgical cases (e.g., incarcerated hernia).
Patients with known bleeding disorders or coagulation abnormalities.
Patients receiving anticoagulant therapy (e.g., Warfarin, DOACs) or those receiving a combination of antiplatelet and anticoagulant therapy.
Patients undergoing robot-assisted inguinal hernia repair.
Patients judged unsuitable for the study by the attending physician or investigator.
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 03 Month 19 Day
Date of IRB - 2026 Year 03 Month 19 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069968
Disclaimer: Curated by HT Syndication.
